Featuring an interview with Dr Kathleen N Moore, including the following topics:
- Overview of the mechanism of action and pharmacology of antibody-drug conjugates (ADCs) (0:00)
- Comparing toxicities of conventional chemotherapy and ADCs (6:26)
- Potential of ADCs as maintenance therapy for ovarian cancer (11:35)
- Treatment based on platinum sensitivity and homologous recombination-deficiency status (15:10)
- Case: A woman in her mid 70s presenting with Stage IV ovarian cancer receives raludotatug deruxtecan (18:46)
- Case: A woman in her mid 60s with relapsed/refractory ovarian cancer receives mirvetuximab soravtansine (41:22)
- Case: A woman in her early 70s with relapsed/refractory ovarian cancer receives multiple ADCs in clinical trials (45:57)
Fler avsnitt av Research To Practice | Oncology Videos
Visa alla avsnitt av Research To Practice | Oncology VideosResearch To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
